2182
A clinical trial was initiated to evaluate the recommended dose of cyclophosphamide in combination with bortezomib and dexamethasone as induction treatment before stem cell transplantation for younger patients with newly diagnosed multiple myeloma ( MM ) .
 Chemical: cyclophosphamide; Chemical: bortezomib; Chemical: dexamethasone; Disease: multiple myeloma; Disease: MM
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Disease, Chemical 
Text: {0} 
Answer:
 Chemical: cyclophosphamide; Chemical: bortezomib; Chemical: dexamethasone; Disease: multiple myeloma; Disease: MM